Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/RHO stock hub

ETR/RHO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/RHOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

275B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/RHO

In the news

Latest news · ETR/RHO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 12.3P50 15.7P75 20.2

Trailing P/E19.9

P25 16.4P50 20.9P75 30.4

ROE37.3

P25 -6.7P50 8.5P75 17.2

ROIC30.7

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/RHO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

CHF

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	103,249
Employees Change	-356%
Employees Change Percent	-0.34
Enterprise value	EUR 298.8B
Exchange	Deutsche Börse Xetra
Financial currency	CHF
First seen	2026-05-10
Industry	Biotechnology
Isin	CH0012032113
Last refreshed	2026-05-10
Market cap	EUR 275B
Price	EUR 354
Price currency	EUR
Rev Per Employee	659,086.99x
Sector	Healthcare
Sic	2834
Symbol	etr/RHO
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.03%
EV Earnings	21.6x
EV/EBIT	13.07x
EV/EBITDA	11.25x
EV/FCF	18.42x
EV/Sales	4.32x
FCF yield	5.9%
Forward P/E	15.26x
P/B ratio	6.76x
P/E ratio	19.88x
P/S ratio	4.04x
PE Ratio10 Y	20.24x
PE Ratio3 Y	22.52x
PE Ratio5 Y	20.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.08%
EBITDA Margin	37.95%
FCF margin	23.84%
Gross margin	74.49%
Gross Profit	EUR 50.7B
Gross Profit Growth	-0.6%
Gross Profit Growth Q	-1.22%
Gross Profit Growth3 Y	1.48%
Gross Profit Growth5 Y	0.43%
Net Income	EUR 13.8B
Net Income Growth	55.61%
Net Income Growth Q	170.93%
Net Income Growth3 Y	6.65%
Net Income Growth5 Y	3.15%
Pretax Margin	26.79%
Profit Margin	20.33%
Profit Per Employee	EUR 133,990
ROA	12.94
Roa5y	13.31
ROCE	28.83
ROE	37.27
Roe5y	38.06
ROIC	30.65
Roic5y	32.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.87%
Div CAGR10	4.8%
Div CAGR3	7.98%
Div CAGR5	7.74%
EPS Growth	55.58
EPS Growth Q	171.3
EPS Growth3 Y	6.61
EPS Growth5 Y	3.23
FCF Growth	-8.82%
FCF Growth Q	-6.66%
FCF Growth3 Y	6.84%
FCF Growth5 Y	3%
OCF Growth	-6.18%
OCF Growth Q	-3.51%
OCF Growth10 Y	0.15%
OCF Growth3 Y	5.38%
OCF Growth5 Y	2.66%
Revenue Growth	1.54x
Revenue Growth Q	-0.42x
Revenue Growth3 Y	1.5x
Revenue Growth5 Y	0.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.63
Assets	EUR 108.2B
Cash	EUR 16.6B
Current Assets	EUR 42.3B
Current Liabilities	EUR 30.6B
Debt	EUR 35.7B
Debt EBITDA	EUR 1.36
Debt Equity	EUR 0.88
Debt FCF	EUR 2.2
Equity	EUR 40.7B
Interest Coverage	17.66
Liabilities	EUR 67.5B
Long Term Assets	EUR 65.9B
Long Term Liabilities	EUR 36.9B
Net Cash	EUR -19B
Net Cash By Market Cap	EUR -6.92
Net Debt EBITDA	EUR 0.74
Net Debt Equity	EUR 0.47
Net Debt FCF	EUR 1.17
Tangible Book Value	EUR 7.5B
Tangible Book Value Per Share	EUR 9.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Inventory Turnover	2.14
Net Working Capital	EUR -252.4M
Quick ratio	1.05
Working Capital	EUR 11.5B
Working Capital Turnover	EUR 5.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.13%
Dividend Growth	23.31%
Dividend Growth Years	4%
Dividend per share	EUR 11.96
Dividend Years	28
Dividend Yield	3.35%
Ex Div Date	2026-03-12
Last Dividend	EUR 11.96
Payout Frequency	Annual
Payout Ratio	60.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.85%
200-day SMA	340.7
50-day SMA	365.2
50-day SMA vs 200-day SMA	50over200
All Time High	420.8
All Time High Change	-15.87%
All Time High Date	2026-02-27
All Time Low	272.6
All Time Low Change	29.86%
All Time Low Date	2025-08-12
ATR	6.33
Ch YTD	-2.64
High	355.8
High52	420.8
High52 Date	2026-02-27
High52ch	-15.87%
Low	352.8
Low52	272.6
Low52 Date	2025-08-12
Low52ch	29.86%
Ma50ch	-3.06%
Price vs 200-day SMA	3.9%
RSI	45.22
RSI Monthly	0
RSI Weekly	48.21
Sharpe ratio	0.75x
Sortino ratio	1.45
Total Return	3.22%
Tr YTD	0.54
Tr1m	1.14%
Tr1w	-0.28%
Tr3m	-8.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 22.5B
Operating Income Growth	3.35
Operating Income Growth Q	7.74
Operating Income Growth3 Y	5.2
Operating Income Growth5 Y	1.99
Operating margin	33.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	652,938,195%
Net Borrowing	-566,432,133.1
Shares Insiders	17.93%
Shares Institutions	15.4%
Shares Qo Q	0%
Shares Yo Y	0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 15.3B
Average Volume	234.65x
Bv Per Share	45.63
CAPEX	EUR -4B
Ch1m	1.14
Ch1w	-0.28
Ch1y	18
Ch3m	-11.19
Ch6m	18
Change	-0.9%
Change From Open	-0.51
Close	357.2
Days Gap	-0.39
Depreciation Amortization	3,368,033,839.8
Dollar Volume	19,116
Earnings Date	2026-07-23
EBIT	EUR 22.5B
EBITDA	EUR 25.8B
EPS	EUR 17.23
F Score	5
FCF	EUR 16.2B
FCF EV Yield	5.43x
Financing CF	-12,210,259,917
Fiscal Year End	December
Founded	1,896
Goodwill	8,176,704,318.8
Graham Number	144.86139
Graham Upside	-59.08
Income Tax	EUR 3.4B
Investing CF	-9,175,954,475
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Lynch Fair Value	EUR 89.04
Lynch Upside	-74.85
Ma150	356.9
Ma150ch	-0.83%
Ma20	357
Ma20ch	-0.84%
Net CF	-1,496,207,958
Next Earnings Date	2026-07-23
Open	355.8
P FCF Ratio	16.95
P OCF Ratio	13.58
Payment Date	2026-03-16
Position In Range	40
Ppne	25,029,970,214.5
Price Date	2026-05-08
Price EBITDA	EUR 10.65
Ptbv Ratio	36.63
Relative Volume	0.23x
Revenue	68,050,072,776x
SBC By Revenue	1.35x
Share Based Comp	920,495,492
Tax By Revenue	5.01x
Tax Rate	18.7%
Tr6m	21.85%
Volume	54
Z Score	4.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/RHO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$12.0 annual per share

Payout ratio

+60.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.7%

4 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2026-03-12

Performance

ETR/RHO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/RHO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.4%

Share of float held by funds and institutions

Insider ownership

+17.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

ETR/RHO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.2

Neutral momentum band

Price vs 200-day MA

+3.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/RHO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/RHO stock rating?

etr/RHO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/RHO analysis?

The full report lives at /stocks/etr/RHO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/RHO?

The latest report frames etr/RHO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/RHO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.